A Necessidade Imperiosa de Consulta de Grupo Multidisciplinar de Oncologia Molecular em Portugal

João Martins Gama; Rui Caetano Oliveira

doi:10.20344/amp.24485

The Imperious Need for Molecular Tumor Boards in Portugal

Authors

João Martins Gama Centro de Anatomia Patológica Germano de Sousa. Coimbra. https://orcid.org/0000-0001-5274-4114
Rui Caetano Oliveira Centro de Anatomia Patológica Germano de Sousa. Coimbra. & Biophysics Institute. Faculdade de Medicina. Universidade de Coimbra. Coimbra. & Area of Environment Genetics and Oncobiology. Coimbra Institute for Clinical and Biomedical Research (iCBR). Faculdade de Medicina. Universidade de Coimbra. Coimbra. https://orcid.org/0000-0002-7202-8059

DOI:

https://doi.org/10.20344/amp.24485

Keywords:

Biomarkers, Tumor, Medical Oncology, Neoplasms/drug therapy, Neoplasms/genetics, Pathology, Molecular, Precision Medicine

Abstract

n/a.

Downloads

Download data is not yet available.

References

Horgan D, Tanner M, Aggarwal C, Thomas D, Grover S, Basel-Salmon L, et al. Precision oncology: a global perspective on implementation and policy development. JCO Glob Oncol. 2025;11:e2400416. DOI: https://doi.org/10.1200/GO-24-00416

Malone ER, Oliva M, Sabatini PJ, Stockley TL, Siu LL. Molecular profiling for precision cancer therapies. Genome Med. 2020;12:8. DOI: https://doi.org/10.1186/s13073-019-0703-1

Belcaid L, Højgaard M, Tuxen I, Spanggaard I, Lassen U, Robinson L, et al. Copenhagen Prospective Personalized Oncology (CoPPO)—impact of comprehensive genomic profiling in more than 2000 patients in a phase I setting. Ann Oncol. 2025;36:1078-87. DOI: https://doi.org/10.1016/j.annonc.2025.04.004

Massard C, Michiels S, Ferté C, Le Deley MC, Lacroix L, Hollebecque A, et al. High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: results of the MOSCATO 01 Trial. Cancer Discov. 2017;7:586-95. DOI: https://doi.org/10.1158/2159-8290.CD-16-1396

Rodon J, Soria JC, Berger R, Miller WH, Rubin E, Kugel A, et al. Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial. Nat Med. 2019;25:751-8. DOI: https://doi.org/10.1038/s41591-019-0424-4

French Genomic Medicine Initiative. PFMG 2025. [cited 2026 Jan 10]. Available from: https://pfmg2025.fr/en/2025-french-genomic-medicine-initiative/.

National Health Service England. NHS Genomic Medicine Service. [cited 2026 Jan 10]. Available from: https://www.england.nhs.uk/genomics/nhs-genomic-med-service/.

Patel M, Kato SM, Kurzrock R. Molecular tumor boards: realizing precision oncology therapy. Clin Pharmacol Ther. 2018;103:206-9. DOI: https://doi.org/10.1002/cpt.920

Willemsen AE, Krausz S, Ligtenberg MJ, Grünberg K, Groen HJ, Voest EE, et al. Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations. Br J Cancer. 2019;121:34. DOI: https://doi.org/10.1038/s41416-019-0489-3

Downloads

24485_AOP.pdf

Published

2026-07-01

How to Cite

Martins Gama J, Caetano Oliveira R. The Imperious Need for Molecular Tumor Boards in Portugal. Acta Med Port [Internet]. 2026 Jul. 1 [cited 2026 Jul. 9];. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/24485

Download Citation

Issue

In Press

Section

Perspective

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.